261 related articles for article (PubMed ID: 6351057)
1. Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes.
Barsoum J; Varshavsky A
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5330-4. PubMed ID: 6351057
[TBL] [Abstract][Full Text] [Related]
2. Acquisition and loss of amplified genes: dramatic effects of hormones, tumor promoters and cytotoxic drugs.
Varshavsky A; Barsoum J; Roninson I; Snapka R
Princess Takamatsu Symp; 1983; 14():235-54. PubMed ID: 6394591
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion.
Varshavsky A
Cell; 1981 Aug; 25(2):561-72. PubMed ID: 7285113
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor promoter 12-O-tetradecanoylphorbol-13-acetate on recovery of methotrexate-, N-(phosphonacetyl)-L-aspartate-, and cadmium-resistant colony-forming mouse and hamster cells.
Bojan F; Kinsella AR; Fox M
Cancer Res; 1983 Nov; 43(11):5217-21. PubMed ID: 6616458
[TBL] [Abstract][Full Text] [Related]
5. UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells.
Tlsty TD; Brown PC; Schimke RT
Mol Cell Biol; 1984 Jun; 4(6):1050-6. PubMed ID: 6738530
[TBL] [Abstract][Full Text] [Related]
6. The effect of 12-O-tetradecanoylphorbol-13-acetate and other tumor promoters on the colony formation of rat tracheal epithelial cells in culture.
Mass MJ; Nettesheim P; Gray TE; Barrett JC
Carcinogenesis; 1984 Dec; 5(12):1597-601. PubMed ID: 6437693
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kinsella AR; Fox M
Int J Cancer; 1988 Jul; 42(1):87-93. PubMed ID: 3391708
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea.
Brown PC; Tlsty TD; Schimke RT
Mol Cell Biol; 1983 Jun; 3(6):1097-107. PubMed ID: 6877240
[TBL] [Abstract][Full Text] [Related]
9. Loss of unstably amplified dihydrofolate reductase genes from mouse cells is greatly accelerated by hydroxyurea.
Snapka RM; Varshavsky A
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7533-7. PubMed ID: 6584871
[TBL] [Abstract][Full Text] [Related]
10. Rapid emergence of methotrexate resistance in cultured mouse cells.
Rath H; Tlsty T; Schimke RT
Cancer Res; 1984 Aug; 44(8):3303-6. PubMed ID: 6744265
[TBL] [Abstract][Full Text] [Related]
11. Effect of 12-O-tetradecanoylphorbol-13-acetate on selection of drug-resistant phenotypes in rodent cells.
Bojan F; Kinsella AR; Fox M
IARC Sci Publ; 1984; (56):265-73. PubMed ID: 6536598
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
Denis N; Kitzis A; Kruh J; Dautry F; Corcos D
Oncogene; 1991 Aug; 6(8):1453-7. PubMed ID: 1886715
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes.
Parkinson EK; Pera MF; Emmerson A; Gorman PA
Carcinogenesis; 1984 Aug; 5(8):1071-7. PubMed ID: 6204790
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoters specifically and reversibly disturb development and behavior of Caenorhabditis elegans.
Miwa J; Tabuse Y; Furusawa M; Yamasaki H
J Cancer Res Clin Oncol; 1982; 104(1-2):81-7. PubMed ID: 7130252
[TBL] [Abstract][Full Text] [Related]
15. Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.
Yamasaki H; Martel N; Fusco A; Ostertag W
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2075-9. PubMed ID: 6326103
[TBL] [Abstract][Full Text] [Related]
16. The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells.
Yuspa SH; Ben T; Hennings H
Carcinogenesis; 1983 Nov; 4(11):1413-8. PubMed ID: 6139180
[TBL] [Abstract][Full Text] [Related]
17. Sp1 involvement in the 4beta-phorbol 12-myristate 13-acetate (TPA)-mediated increase in resistance to methotrexate in Chinese hamster ovary cells.
Noé V; Alemany C; Nicolás M; Ciudad CJ
Eur J Biochem; 2001 Jun; 268(11):3163-73. PubMed ID: 11389717
[TBL] [Abstract][Full Text] [Related]
18. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
Urlaub G; Landzberg M; Chasin LA
Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
[TBL] [Abstract][Full Text] [Related]
19. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate.
Corin RE; Turner T; Szabo P
Biochemistry; 1986 Jul; 25(13):3768-73. PubMed ID: 3461851
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
Bürkle A; Heilbronn R; zur Hausen H
Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
